# Comparative Study of Individualized Sensitivity-Directed Chemotherapy Versus DTIC

> **NCT00779714** · PHASE3 · UNKNOWN · sponsor: **University of Wuerzburg** · enrollment: 360 (estimated)

## Conditions studied

- Melanoma

## Interventions

- **DRUG:** DTIC (dacarbazine)
- **DRUG:** paclitaxel + cisplatin
- **DRUG:** treosulfan + cytarabine

## Key facts

- **NCT ID:** NCT00779714
- **Lead sponsor:** University of Wuerzburg
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-10
- **Primary completion:** 2012-10
- **Final completion:** 2013-04
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2008-10-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00779714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00779714, "Comparative Study of Individualized Sensitivity-Directed Chemotherapy Versus DTIC". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00779714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*